JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-11-01 12300121m89暂无昵称来自广东省

偏重的研究方向：肿瘤
经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。

20 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-10-22 Dream_eyes 来自江西省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：60 Reviewer(s) invited about 16 hours ago
有点离谱啊

20 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-10-25 ms6000000781953697 来自浙江省

偏重的研究方向：肿瘤
经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-10-24 ms3000001466183845 来自陕西省

这个杂志为啥这么慢

22 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-08-25 ms8000001459205604 来自广西

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;生信加细胞功能实验
经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了

49 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-09-13 ms8000001459205604 来自广西

一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？

25 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-09-28 ms7000001243028264 来自湖北省

偏重的研究方向：肿瘤
经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-10-12 ms4000001917969473

偏重的研究方向：泌尿外科
经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-09-26 ms4000000067455992

偏重的研究方向：肿瘤;癌症;生信
经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢

19 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164200, encodeId=ba80216420033, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：60 Reviewer(s) invited about 16 hours ago 有点离谱啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b26464016, createdName=Dream_eyes, createdTime=Sun Oct 22 14:57:53 CST 2023, time=2023-10-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2164904, encodeId=4261216490443, content=偏重的研究方向：肿瘤 经验分享：我真的无语了，8月底投的。现在10月底了，还在邀请审稿人。一点消息都没有。大家都这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba778853890, createdName=ms6000000781953697, createdTime=Wed Oct 25 19:31:57 CST 2023, time=2023-10-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164723, encodeId=43fd2164e2381, content=这个杂志为啥这么慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Tue Oct 24 22:38:31 CST 2023, time=2023-10-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154512, encodeId=7e702154512b4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：8月4号已投稿，8月5号邀请6个审稿人，8月14号1个审稿人接受审稿，现在没消息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Fri Aug 25 11:04:29 CST 2023, time=2023-08-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2160229, encodeId=639a2160229c3, content=偏重的研究方向：肿瘤 经验分享：垃圾杂志真的慢两个半月一点进展都没有耽误时间的很 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6758358455, createdName=ms7000001243028264, createdTime=Thu Sep 28 19:35:14 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2162351, encodeId=0bc721623516f, content=偏重的研究方向：泌尿外科 经验分享：这个杂志最近是不是老找不见审稿人？一个多月了，还是没有审稿人审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2586476968, createdName=ms4000001917969473, createdTime=Thu Oct 12 13:59:30 CST 2023, time=2023-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159702, encodeId=571f2159e0246, content=偏重的研究方向：肿瘤;癌症;生信 经验分享：感觉我和大家遇到的情况不一样诶是啥子情况 8/09 redeay to assign editor 8/13 editor appointed 8/22 1 reviewer accepted 8/25 2 reviewer acceptes 8/22-8/31有从2变成1再变成2，盲猜有个审稿人看了文章退出评审了，后面又有个审稿人接受审稿了 9/19 1 reviewer report accepted 到今天状态没更新，感觉只有部分人的学编被换了，我这个还是在走流程不过很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Tue Sep 26 00:20:31 CST 2023, time=2023-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154555, encodeId=51522154555cb, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：临床应用;肿瘤 经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59201677662, createdName=水中D石头, createdTime=Fri Aug 25 16:29:29 CST 2023, time=2023-08-25, status=1, ipAttribution=浙江省)]

2023-08-25 水中D石头来自浙江省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：临床应用;肿瘤
经验分享：7月初投稿，2周后返修，就一个审稿人，2天后上传，3周后显示接收，非常有效效率，nice

23 7

展开7条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务